JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Others

A1267 Adapalene

Target: RARs

Summary: RARβ and RARγ agonist

insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
A8327 Verteporfin

Target: YAP

Summary: Photosensitizer used in photodynamic therapy

insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
A8537 Thioridazine HCl

Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors

Summary: Calcium channel protein inhibitor
A8814 NH125
1 Citation

Target: eEF-2

Summary: Selective eEF-2 kinase inhibitor

≥25.9 mg/mL
B3179 PTC-209

Target: BMI-1

Summary: Bmi-1 inhibitor,cell-permeable and small-molecule

≥24.75 mg/mL
B4758 BAPTA-AM
3 Citation

Target: Calcium chelator

Summary: calcium chelator, selective and membrane permeable

insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL
B8015 ML216

Target: BLM

Summary: BLM helicase inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
B4857 YL-109

Summary: novel anticancer agent

insoluble in H2O; ≥11.4 mg/mL
B6008 BPTES

Target: Glutaminases

Summary: GLS inhibitor

insoluble in H2O; insoluble in EtOH; ≥18 mg/mL
B6018 Disodium (R)-2-Hydroxyglutarate

Summary: inhibitor of α-ketoglutarate-dependent dioxygenases

insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL